Takeda acquiring TiGenix for €520M

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it will acquire TiGenix N.V. (Euronext:TIG; NASDAQ:TIG) for €1.78 per share in cash, or €520 million ($617.6 million). The price is an 82% premium to TiGenix’ close of €0.98 in Brussels on Jan. 4, before the deal was announced...